metformin has been researched along with Anxiety Neuroses in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"Cigarette smoking is the leading cause of preventable disease and death in the United States, with more persons dying from nicotine addiction than any other preventable cause of death." | 3.88 | Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. ( Blendy, JA; Brynildsen, JK; Jin, S; Kim, SF; Lee, BG; Perron, IJ, 2018) |
" A low prevalence of AD in patients with T2D was associated with residency in urban areas, the comorbidity of hemiplegia or paraplegia, the usage of metformin and sulfonylureas, and rapid-acting insulin injection therapy." | 3.85 | Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000-2010. ( Hsieh, HM; Huang, CJ; Jiang, HJ; Lin, CH; Tu, HP; Wang, PW, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brynildsen, JK | 1 |
Lee, BG | 1 |
Perron, IJ | 1 |
Jin, S | 1 |
Kim, SF | 1 |
Blendy, JA | 1 |
Tu, HP | 1 |
Lin, CH | 1 |
Hsieh, HM | 1 |
Jiang, HJ | 1 |
Wang, PW | 1 |
Huang, CJ | 1 |
Reddy, BR | 1 |
Maitra, S | 1 |
Jhelum, P | 1 |
Kumar, KP | 1 |
Bagul, PK | 1 |
Kaur, G | 1 |
Banerjee, SK | 1 |
Kumar, A | 1 |
Chakravarty, S | 1 |
3 other studies available for metformin and Anxiety Neuroses
Article | Year |
---|---|
Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anxiety Disorders; Drug Evaluati | 2018 |
Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000-2010.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anxiety Disorders; Cerebrovascular Dis | 2017 |
Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats.
Topics: Animals; Antioxidants; Anxiety Disorders; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes M | 2016 |